You are here

Injecting drug users (IDUs)

Bridiging the Gaps Tajikistan

Using drugs reducing risks - Improving access to healthcare for people who use drugs in Tajikistan

by
Bridging the Gaps

BRIDGING THE GAPS:  an international HIV Programme on health and rights for LGBT people, sex workers and people who use drugs.  Video from the programme on improving access to healthcare for people who use drugs in Tajikistan

In Tajikistan an estimated 25,000 people are using drugs....

Tags: Injecting drug users (IDUs), People who use drugs (PUD), Central Asia, Harm reduction, Inequalities in health, Universal access
Read more
Bridging the Gaps Ukraine

Today’s youth, tomorrow’s key populations?

by
Bridiging the Gaps

BRIDGING THE GAPS:  an international HIV Programme on health and rights for LGBT people, sex workers and people who use drugs.  Video from the programme on supporting adolescents at risk of HIV in Ukraine. 

Tags: Heterosexuals, Injecting drug users (IDUs), People who use drugs (PUD), Women, Eastern Europe, Care and support, Harm reduction, Inequalities in health, Social issues
Read more

Bridging the Gaps: Health and rights of key populations: engaging underserved key population in Kyrgyztan: what works?

by
Dinara Magdybaeva, Aida Karipova, David Yanchinov

Within the framework of the programme “Bridging the Gaps: Health and rights of key populations”, operational research was conducted among people who inject drugs (PWID), sex workers (SW) and lesbian, gay, bisexual and transgender (LGBT) people, as well as outreach workers and managers of local...

Tags: Gay men and other MSM, Injecting drug users (IDUs), LGBTI, Men having sex with men (MSM), People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Prisoners (ex-), Sex workers, Women, Youth, Central Asia, Advocacy, Affordability, Care and support, Co-infections, Inequalities in health, Monitoring and Evaluation, Research, Resource mobilisation, STI's, Stigma and discrimination, Testing and counselling, Treatment, Treatment as prevention (TasP), Viral hepatitis
Read more
European Drug Report 2016 - Trends and Developments

European Drug Report 2016: Trends and Developments

by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin, Country Overviews and Perspectives on Drugs, it makes up...

Tags: Health care professionals, Injecting drug users (IDUs), NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Laws and regulations, Legislation, Monitoring and Evaluation, Policy, Prevention, Research, Treatment
Read more

HEPscreen: Screening for hepatitis B and C among migrants in the European Union

Chronic viral hepatitis B and C are the leading causes of liver cancer and cirrhosis. In Europe, it is estimated that about 14 million people are chronically infected with the hepatitis B virus and nine million people with the hepatitis C virus. Migrants from endemic areas are particularly at...

BORDERNETwork. Highly active prevention: scale up HIV/AIDS/STI prevention, diagnostic and therapy across sectors and borders in CEE and SEE

Based on multi-sectoral network commitment, the partnership elaborates on outcomes of the EU project BORDERNET and produces new practice-relevant models transferred to affected regions in Central, Eastern and South Eastern Europe. 8 EU Member States (Austria, Germany, Poland, Slovak Republic,...

Twitter News